China Drug Safety Remains Front and Center In Chromium Capsule Scandal
This article was originally published in The Gold Sheet
Executive Summary
China’s latest product safety scandal could have far-reaching implications, potentially even disrupting China's tendering system for essential medicines.
You may also be interested in...
Dismissing Requests of World’s Gelatin Makers, FDA Asks USP to Add Tests for Melamine to Monograph
Undeterred by arguments from gelatin manufacturers that there is no economic motivation to put melamine in gelatin, FDA asks USP to require additional testing for the potential adulterant.
Dismissing Requests of World’s Gelatin Makers, FDA Asks USP to Add Tests for Melamine to Monograph
Undeterred by arguments from gelatin manufacturers that there is no economic motivation to put melamine in gelatin, FDA asks USP to require additional testing for the potential adulterant.
Hit Collaterally By Popular Backlash Following Vaccine Scandals, China's Sinovac Could Exploit High Quality Standards To Emerge As Winner
BEIJING - Despite being hit by a succession of vaccine scandals and resulting public fears of domestically produced biologics, China's leading vaccine developer could ultimately emerge as a more powerful player due to its sterling reputation in a field of tarnished competitors